The Journal of Immunology, Vol 156, Issue 11 4100-4106, Copyright © 1996 by American Association of Immunologists

ARTICLES

TCR-independent activation of human CD4+ 45RO- T cells by anti-CD28 plus IL-2: Induction of clonal expansion and priming for a Th2 phenotype

V Brinkmann, B Kinzel and C Kristofic
Department of Asthma and Allergy Research, Pharmaceuticals Division, Ciba-Geigy Limited, Basel, Switzerland.

In this study we show that uncommitted human CD4+ CD45RA+ RO- CD25- CD71- HLA-DR- T cells can be primed for a Th2 phenotype before they encounter TCR signals and before they are exposed to IL-4. We found that >99% of uncommitted T cells proliferated upon costimulation by immobilized anti-CD3 plus anti-CD28 mAbs and differentiated into pure Th1 cells. In contrast, uncommitted T cells did not respond to stimulation by either anti-CD3 or anti-CD28, or by IL-2 alone. Interestingly, 5% of uncommitted T cells proliferated efficiently in response to stimulation by immobilized anti-CD28 plus IL-2 (in the absence of TCR/CD3 signals) and differentiated into pure Th2 "precursor" cells. Like murine CD4+ NK1.1+ T cells, human Th2 precursors promptly expressed mRNA for Th2 cytokines upon stimulation via the TCR/CD3 complex by anti-CD3 mAb or staphylococcal enterotoxin B, and secreted up to 50 ng of IL-4, IL-5, and IL-13 per 10(6) cells. Th2 "precursors" developed only in the complete absence of IL-4, as addition of 0.1 U (5 pg) of exogenous IL-4 suppressed their clonal expansion by >90%, whereas addition of neutralizing anti-IL-4 mAb had no effect. Together these results suggest that, in vivo, a significant fraction of uncommitted T cells may be primed for a Th2 phenotype independent of Ag and IL-4 if they are exposed to Th1 cell-derived IL-2 and simultaneously interact with accessory cells bearing the natural CD28 ligands B7-1 and B7-2. When stimulated by specific Ag, such primed Th2 precursor cells may provide a source of IL-4 to promote Th2 immunity.

This article has been cited by other articles:

				V. Natarajan, R. A. Lempicki, I. Sereti, Y. Badralmaa, J. W. Adelsberger, J. A. Metcalf, D. A. Prieto, R. Stevens, M. W. Baseler, J. A. Kovacs, et al. Increased peripheral expansion of naive CD4+ T cells in vivo after IL-2 treatment of patients with HIV infection PNAS, August 6, 2002; 99(16): 10712 - 10717. [Abstract] [Full Text] [PDF]

				M. Kubo, M. Yamashita, R. Abe, T. Tada, K. Okumura, J. T. Ransom, and T. Nakayama CD28 Costimulation Accelerates IL-4 Receptor Sensitivity and IL-4-Mediated Th2 Differentiation J. Immunol., September 1, 1999; 163(5): 2432 - 2442. [Abstract] [Full Text] [PDF]

				S. N. Georas, J. E. Cumberland, T. F. Burke, R. Chen, U. Schindler, and V. Casolaro Stat6 Inhibits Human Interleukin-4 Promoter Activity in T Cells Blood, December 15, 1998; 92(12): 4529 - 4538. [Abstract] [Full Text] [PDF]

				R. Moriggl, C. Kristofic, B. Kinzel, S. Volarevic, B. Groner, and V. Brinkmann1 Activation of STAT Proteins and Cytokine Genes in Human Th1 and Th2 Cells Generated in the Absence of IL-12 and IL-4 J. Immunol., April 1, 1998; 160(7): 3385 - 3392. [Abstract] [Full Text] [PDF]

				C. Steel and T. B. Nutman Helminth Antigens Selectively Differentiate Unsensitized CD45RA+CD4+ Human T Cells in Vitro J. Immunol., January 1, 1998; 160(1): 351 - 360. [Abstract] [Full Text] [PDF]

				M. Exley, J. Garcia, S. P. Balk, and S. Porcelli Requirements for CD1d Recognition by Human Invariant Valpha 24+ CD4-CD8- T Cells J. Exp. Med., July 7, 1997; 186(1): 109 - 120. [Abstract] [Full Text] [PDF]